Clinical registries are organized systems that store standardized data on a specific population defined by a disease, condition, or procedure. Information from clinical data registries can be used to evaluate specific outcomes and compare the effectiveness of different treatments. Furthermore, they are utilized to improve quality of care and patient safety.
The Clinical Research and Registries Division strongly encourages registry endeavors for the purposes of advancing scientific knowledge and developing innovative therapies that lead to improved patient care in IR. Previous registry stakeholders include government agencies, industry manufacturers, and other professional societies.
Current registries
SIR Foundation is involved in the development of various registries. SIR members have led and supported the following registries:
BenchMarket Medical (BMM) Sacroplasty Registry
SIR Foundation is collaborating with BMM in a registry to evaluate the effectiveness of sacroplasty procedure. There is limited research on sacroplasty, and it is not commonly completed due to lack of reimbursement. The registry's goal is to collect data from 252 procedures across 7-10 sites. Currently, 5 sites have collected data from 37 procedures.
- Consulting Orthopaedic Associates
- Medical College of Wisconsin
- Reading Hospital
- Summit Medical Center
- VIRA of Central Georgia
SIR Foundation is recruiting additional sites to participate in the sacroplasty registry. Sites that complete 1-2 sacroplasty procedures are encouraged to participate. BMM will work with interested sites to complete the appropriate paperwork and training. For additional information, please contact SIR Foundation Director of Research and Grants.
Venous Access: National Guideline and Registry Development (VANGUARD) Initiative
VANGUARD is a multi-disciplinary initiative that focuses on understanding and improving complications related to central venous access. One of its goals is to develop a unified terminology to support the development of large database tools for data acquisition, storage, transmission, and analysis. Kevin Baskin, MD is the lead investigator of VANGUARD. It was developed from an SIR Foundation RCP in October of 2014 entitled 'Critical issues in chronic central venous access and pathways for investigation.' It was further supported as a MDEpiNet project. In 2016, SIR Foundation organized and held the VANGUARD Symposium at the National Library of Medicine, part of the National Institutes of Health (NIH). This planning meeting focused on the development of standardized vocabulary and registry specification. Dr. Baskin is seeking other funding mechanisms.
Registry Assessment of Peripheral Interventional Devices (RAPID)
RAPID is an MDEpiNet project that focuses on registry development for peripheral arterial intervention. Standard data elements related to the care and treatment of patients with peripheral artery disease are being developed to create a structured dataset that supports pre‐ and post‐market assessment, quality improvement, and safety surveillance of peripheral interventional devices. SIR members have been involved in the initial stages, and they have attended previous planning meetings. SIR continues to participate as an important stakeholder.
Completed Registries
BenchMarket Medical (BMM) Vertebral Compression Fracture (VCF) Registry
SIR Foundation collaborated with BMM to support interventional radiologist participation in the existing VCF Registry. Noridian Healthcare Solutions (NHS) issued a local coverage decision (LCD) requiring outcomes data for vertebral augmentation procedures. By working directly with NHS, BMM provided a standardized approach to submit information to meet these outcomes requirements and comply with the requirements of the LCD. SIR Foundation covered the cost of participation of a limited number of sites to ensure adequate data collection for coverage purposes, as well as to ensure high-quality data submission that will result in improved patient care. As of April 2018, the registry reached its enrollment goal, and it is closed to enrollment. Doug Beall, MD, the lead investigator, is working on manuscripts related to the data.
